Reduced systemic inflammation may lower the inflammatory tone in the brain
The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease
The companys Controlled Metabolic Accelerator (CMA) platform was designed from inception to address obesitys primary driver while explicitly preserving skeletal muscle mass
Participants in the Retatrutide Triumph trial are losing close to 30% of their weight, among many other health benefits While Retatrutide is NOT approved by the FDA, it is available under a "research only" provision from many companies
Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men
Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR